Compare IVA & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVA | EVER |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 804.2M | 929.5M |
| IPO Year | 2020 | 2018 |
| Metric | IVA | EVER |
|---|---|---|
| Price | $6.52 | $24.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $16.00 | ★ $33.00 |
| AVG Volume (30 Days) | ★ 414.1K | 355.1K |
| Earning Date | 09-29-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 284.14 |
| EPS | N/A | ★ 1.44 |
| Revenue | $19,929,536.00 | ★ $644,656,000.00 |
| Revenue This Year | N/A | $37.47 |
| Revenue Next Year | N/A | $14.11 |
| P/E Ratio | ★ N/A | $17.21 |
| Revenue Growth | N/A | ★ 57.83 |
| 52 Week Low | $2.11 | $17.35 |
| 52 Week High | $7.98 | $30.03 |
| Indicator | IVA | EVER |
|---|---|---|
| Relative Strength Index (RSI) | 78.22 | 39.24 |
| Support Level | $4.48 | $24.58 |
| Resistance Level | $5.17 | $26.87 |
| Average True Range (ATR) | 0.25 | 0.97 |
| MACD | 0.19 | -0.18 |
| Stochastic Oscillator | 94.28 | 14.15 |
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.